lorbriqua 25mg tablet

Therapeutic Class: ANTI NEOPLASTICS
Action Class: Tyrosine kinase inhibitors
Chemical Class: Phenylpropanoid derivatives
Habit Forming: No

USES
Treatment of Non-small cell lung cancer

SIDE EFFECTS
Fatigue
Diarrhea
Edema (swelling)
High blood pressure
Cough
Joint pain
Peripheral neuropathy (tingling and numbness of feet and hand)
Weight gain
Breathlessness
Mood changes
Hypercholesterolemia (high cholesterol)
Increased triglyceride level in blood

